Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

SELL
$35.53 - $43.38 $1.23 Million - $1.51 Million
-34,750 Reduced 24.81%
105,300 $4.3 Million
Q3 2022

Oct 28, 2022

SELL
$51.24 - $58.89 $1.24 Million - $1.43 Million
-24,200 Reduced 14.73%
140,050 $7.45 Million
Q2 2022

Jul 28, 2022

SELL
$51.49 - $81.64 $124,863 - $197,977
-2,425 Reduced 1.45%
164,250 $9.58 Million
Q1 2022

Apr 25, 2022

SELL
$60.03 - $76.49 $1.7 Million - $2.17 Million
-28,325 Reduced 14.53%
166,675 $12.7 Million
Q4 2021

Jan 27, 2022

BUY
$47.97 - $62.21 $957,577 - $1.24 Million
19,962 Added 11.4%
195,000 $11.7 Million
Q3 2021

Oct 25, 2021

BUY
$54.64 - $61.3 $136,600 - $153,250
2,500 Added 1.45%
175,038 $9.8 Million
Q2 2021

Jul 29, 2021

SELL
$59.18 - $69.99 $608,725 - $719,917
-10,286 Reduced 5.63%
172,538 $10.5 Million
Q1 2021

Apr 26, 2021

BUY
$59.31 - $78.82 $2.64 Million - $3.51 Million
44,500 Added 32.17%
182,824 $12.8 Million
Q4 2020

Jan 26, 2021

BUY
$50.47 - $66.26 $4.11 Million - $5.39 Million
81,400 Added 143.0%
138,324 $8.28 Million
Q3 2020

Oct 27, 2020

BUY
$51.97 - $63.0 $779,550 - $945,000
15,000 Added 35.78%
56,924 $3.42 Million
Q2 2020

Jul 29, 2020

BUY
$30.8 - $52.47 $1.29 Million - $2.2 Million
41,924 New
41,924 $2.2 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Zweig Di Menna Associates LLC Portfolio

Follow Zweig Di Menna Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zweig Di Menna Associates LLC with notifications on news.